Development of commercial-scale, rapid, microbial detection system for PathoGenetix, Inc.
Product development partner for commercial
scale rapid microbial detection system.
Our client asked:
PathoGenetix selected Sagentia Innovation as their product
development partner to take the current laboratory prototype using
their proprietary GSS technology and help turn it into a technically
and commercially successful platform.
The project story:
We were involved across the product development lifecycle:
• Concept validation and VoC analysis across worldwide sites to
help the client determine and define their go-to-market strategy.
• Development of the architecture.
• Delivery of all electro-mechanical and electro-optical aspects that
enable the GSS technology to be taken to market.
• Delivery of alpha prototypes.
Results: deliverables and outcomes
• We combined two initial bread board systems into an intuitive
and usable system with a smaller footprint, as well as a lower per
unit cost base.
• The system has the potential to identify the specific pathogen
causing a foodborne illness outbreak – a critical step in defining
the extent of the outbreak, determining the food involved, finding
the source of the contamination and defining the scope of a
product recall.
Our markets
Our consultants, scientists and engineers redefine what’s possible and help R&D groups across the medical, industrial, consumer and food and beverage sectors achieve commercial return from their opportunities.
Our projects
We have completed over 10,000 projects for start-ups and global market leaders alike, from understanding the market & technology landscape through to developing and delivering complex products.